What is Organicell Regenerative Medicine, Inc. (BPSR)?

Organicell Regenerative Medicine, Inc. (BPSR) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of BPSR?

The current price of BPSR is $0.06. Prices are updated in real time on Stocks360.

What is BPSR's price-to-earnings (PE) ratio?

BPSR's trailing twelve-month PE ratio is -0.10, based on current price and earnings per share data available on Stocks360.

Organicell Regenerative Medicine, Inc. (BPSR)

Stock analysis · OTC · Healthcare · Biotechnology

$0.06

Market Cap

N/A

PE (TTM)

-0.10

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

7.14

Day Range

$0.05 – $0.06

52-wk Range

$0.04 – $0.63

Avg Volume

N/A

Volume

3.10M

Organicell Regenerative Medicine, Inc. (BPSR) is a publicly traded company in the Healthcare sector. Latest price: $0.06. Trailing PE -0.10. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc. is an enterprise specializing in the preparation, distribution, and supply of biologically derived cellular and tissue products within the United States. Founded in 2011 and based in Miami, Florida, the company underwent a name change in June 2018, transitioning from its previous identity as Biotech Products Services and Research, Inc. Currently, Organicell Regenerative Medicine maintains a partnership with Regenerative Care Network, with the aim of exploring Zofin's potential therapeutic effects for individuals afflicted with heart failure.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.10×
P/S (TTM)	0.00×
P/B	0.65×
PEG	0.00×
P/FCF (TTM)	0.00×
EV / EBITDA	-0.66×
EV / Sales	-0.25×
Earnings Yield	-834.46%
Free Cash Flow Yield	0.00%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$1.75M
Net Income (TTM)	$0.00
Free Cash Flow (TTM)	-$1.38M
Net Debt	-$1.75M
Working Capital	$155.00K
Gross Margin	81.52%
Operating Margin	-59.10%
Net Margin	-55.59%
Return on Equity	455.87%
Return on Invested Capital	-511.01%